Priavoid GmbH
- Biotech or pharma, therapeutic R&D
Treating neurodegenerative disorders with orally available oligomer detanglers. Fully recruited Ph II study in Alzheimer's and several pre-clinical programs in PD, ALS and related indications.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}